Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Early Detection of Dysfunctional Vascular Endothelium

Provides methods that allow for real time detection of endothelial dysfunction.

Full description

Summary
The present invention provides methods that allow for real time
detection of endothelial dysfunction, particularly arterial
endothelial dysfunction, in major blood vessels by imaging
microbubbles retained on vessel endothelium after microbubble
injection. Since ultrasound typically destroys microbubbles, a low
mechanical index pulse sequence scheme in a high frequency
linear array transducer is used to detect retained microbubbles.


Market Value
This invention will improve the outcome of individuals who are at
risk to vascular disease through accurate detection of endothelium
dysfunction, allowing for early therapeutic intervention.


Features and Benefits
• real-time detection of endothelial dysfunction
• non-invasive procedure
• direct visualization methods for more accurate diagnosis

Development status

Early Stage

Patent information

Issued

TID 32

Type of business relationship sought

UNeMed Corporation offers a variety of licensing options and collaborative development opportunities with the University of Nebraska Medical Center.

Licensing contact

Toni Harris
Marketing Specialist
Request more information

More information

For more information about the product please visit website.

Company details

University of Nebraska Medical Center / UNeMed Corporation
Technology Marketing and Licensing for The University of Nebraska Medical Center

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Biomarkers for sepsis and infectious diseases
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us